Radiosensitized Treatment of Primary or Metastatical Malignant Brain Tumors with Hematoporphyrin Derivative

Authors

  • L. Bloznelytė-Plėšnienė Vilnius University
  • L. Rutkovskienė Vilnius University

Abstract

Human brain is not tolerant to amounts of gamma radiation up to 60 Gy that are typically used by traditional oncological radiation therapy. This amount can be considerably reduced if the gamma radiation is applied to malignant tumors sensibilized by a derivative of hematoporphyrin (HpD) Several important questions arise concerning this methodology: what is the optimal wavelength of ionizing radiation. What is an effective regime and dosage of radiation. Answers to these questions depend on the morphological type of the tumor. In the present study we refer to the results of the treatment of 48 patients with malignant brain tumors. Ill. 4, bibl. 15 (in English; summaries in English, Russian and Lithuanian).

Downloads

Published

2006-04-19

How to Cite

Bloznelytė-Plėšnienė, L., & Rutkovskienė, L. (2006). Radiosensitized Treatment of Primary or Metastatical Malignant Brain Tumors with Hematoporphyrin Derivative. Elektronika Ir Elektrotechnika, 68(4), 83-86. Retrieved from https://eejournal.ktu.lt/index.php/elt/article/view/10660

Issue

Vol. 68 No. 4 (2006)

Section

T 115 MEDICINE TECHNOLOGY

License

The copyright for the paper in this journal is retained by the author(s) with the first publication right granted to the journal. The authors agree to the Creative Commons Attribution 4.0 (CC BY 4.0) agreement under which the paper in the Journal is licensed.

By virtue of their appearance in this open access journal, papers are free to use with proper attribution in educational and other non-commercial settings with an acknowledgement of the initial publication in the journal.